LDL Apheresis And/or Human Monoclonal Antibodies as Treatment in Se-vere Dyslipoproteinemia
Rolf Bambauer¹* and Ralf Schiel²
1Formerly: Institute for Blood Purification, Homburg/Saar, Germany
2Clinic for Metabolic Diseases, Medigreif Inselklinik, Heringsdorf, Germany
Bambauer R, Schiel R (2023) LDL Apheresis And/or Human Monoclonal Antibodies as Treatment in Severe Dyslipoproteinemia. Appl Cell Biol, 11(1), 2023 [55-59]